About Inomagen Therapeutics
Inomagen Therapeutics is a private company based in Chicago, Illinois. It has reported $540,000 raised in three offerings on Form D since November 2014.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 5, 2025 | Jun 20, 2025 | $140,000of $3.7M target | 4 | $35,000 | EquityRule 506(c) | Form D ↗ |
| Mar 29, 2024 | Apr 12, 2024 | $200,000of $6.6M target | 4 | $50,000 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 12, 2014 | Nov 24, 2014 | $200,000of $400K target | 8 | $25,000 | DebtRule 506(b) | Form D ↗ |
| Total, three offerings | $540,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Inomagen Therapeutics's Form D filed Jun 20, 2025.